Development of an ex vivo porcine lung model for studying growth Virulence, And signaling of pseudomonas aeruginosa

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3312-3323

  Harrison, Freya ^a   Muruli, Aneesha ^a   Higgins, Steven ^a   Diggle, Stephen P ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N (3 OXODODECANOYL)HOMOSERINE LACTONE; VIRULENCE FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; EX VIVO PORCINE LUNG MODEL; EX VIVO STUDY; LUNG FIBROSIS; LUNG MODEL; NONHUMAN; PORCINE MODEL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE STUDY; QUORUM SENSING; TISSUE INJURY; WILD TYPE;

ADAPTATION, BIOLOGICAL; ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; LUNG; MUTATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SWINE; TRANS-ACTIVATORS; VIRULENCE;

EID: 84904757267     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01554-14     Document Type: Article

References (114)

1. Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222. http://dx.doi.org/10 .1128/CMR.15.2.194-222.2002.
2. Boucher RC. 2004. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur. Respir. J. 23:146-158. http://dx.doi.org/10.1183 /09031936.03.00057003.
3. Govan J, Deretic V. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
4. Eberl L, Tummler B. 2004. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int. J. Med. Microbiol. 294:123-131. http://dx.doi.org/10.1016/j.ijmm .2004.06.022.
5. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, Høiby N, Molin S. 2012. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10:841- 851. http://dx.doi.org/10.1038/nrmicro2907.
6. Hoboth C, Hoffmann R, Eichner A, Henke C, Schmoldt S, Imhof A, Heesemann J, Hogardt M. 2009. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200:118-130. http: //dx.doi.org/10.1086/599360.
7. Huse HK, Kwon T, Zlosnik JEA, Speert DP, Marcotte EM, Whiteley M. 2010. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. mBio 1(4):e00199 -10. http://dx.doi.org/10.1128/mBio .00199-10.
8. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C. 2011. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183:1674-1679. http://dx.doi.org/10.1164 /rccm.201009-1430OC.
9. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487-8492. http://dx.doi.org/10.1073/pnas.0602138103.
10. Wilder CN, Allada G, Schuster M. 2009. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect. Immun. 77:5631-5639. http://dx .doi.org/10.1128/IAI.00755-09.
11. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Høiby N, Sommer MOA, Molin S. 2011. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl. Acad. Sci., U. S. A. 108:7481-7486. http: //dx.doi.org/10.1073/pnas.1018249108.
12. Bjarnsholt T, Jensen PØ, Jakobsen TH, Phipps R, Nielsen AK, Rybtke MT, Tolker-Nielsen T, Givskov M, Høiby N, Ciofu O, Scandinavian Cystic Fibrosis Study Consortium. 2010. Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 5:e10115. http://dx.doi.org/10.1371/journal.pone .0010115.
13. Harrison F. 2007. Microbial ecology of the cystic fibrosis lung. Microbiology 153:917-923. http://dx.doi.org/10.1099/mic.0.2006/004077-0.
14. Moser C, Van Gennip M, Bjarnsholt T, Jensen PØ, Lee B, Hougen HP, Calum H, Ciofu O, Givskov M, Molin S, Høiby N. 2009. Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis. APMIS 117:95- 107. http://dx.doi.org/10.1111/j.1600-0463.2008.00018.x.
15. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D. 2012. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 6:471-474. http://dx.doi.org/10 .1038/ismej.2011.104.
16. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG. 2008. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog. 4:e1000184. http://dx.doi.org/10.1371/journal.ppat.1000184.
17. Benahmed MA, Elbayed K, Daubeuf F, Santelmo N, Frossard N, Namer IJ. 2014. NMR HRMAS spectroscopy of lung biopsy samples: comparison study between human, pig, rat, and mouse metabolomics. Magn. Reson. Med. 71:35-43. http://dx.doi.org/10.1002/mrm.24658.
18. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. 2012. The pig: a model for human infectious diseases. Trends Microbiol. 20:50-57. http://dx.doi.org/10.1016/j.tim.2011.11.002.
19. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG, Inflammation and Host Response to Injury Large Scale Collaborative Research Program. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110:3507-3512. http://dx.doi.org/10.1073/pnas.1222878110.
20. Williams PP, Gallagher JE. 1978. Preparation and long-term cultivation of porcine tracheal and lung organ cultures by alternate exposure to gaseous and liquid medium phases. In Vitro 14:686-696. http://dx.doi .org/10.1007/BF02616165.
21. Williams PP, Gallagher JE. 1978. Cytopathogenicity of Mycoplasma hyopneumoniae in porcine tracheal ring and lung explant organ cultures alone and in combination with monolayer cultures of fetal lung fibroblasts. Infect. Immun. 20:495-502.
22. Diggle SP, Griffin AS, Campbell GS, West SA. 2007. Cooperation and conflict in quorum-sensing bacterial populations. Nature 450:411-414. http://dx.doi.org/10.1038/nature06279.
23. Kümmerli R, Griffin A, West SA, Buckling A, Harrison F. 2009. Viscous medium promotes cooperation in the pathogenic bacterium Pseudomonas aeruginosa. Proc. Biol. Sci. 276:3531-3538. http://dx.doi .org/10.1098/rspb.2009.0861.
24. Palmer KL, Aye LM, Whiteley M. 2007. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189:8079-8087. http://dx.doi.org/10.1128/JB.01138-07.
25. Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187:5267-5277. http://dx.doi.org/10.1128/JB .187.15.5267-5277.2005.
26. Popat R, Crusz SA, Messina M, Williams P, West SA, Diggle SP. 2012. Quorum-sensing and cheating in bacterial biofilms. Proc. Biol. Sci. 279: 4765-4771. http://dx.doi.org/10.1098/rspb.2012.1976.
27. Harrison F, Browning LE, Vos M, Buckling A. 2006. Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biol. 4:21. http://dx.doi.org/10.1186/1741-7007-4-21.
28. Racey D, Inglis RF, Harrison F, Oliver A, Buckling A. 2010. The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa. Evolution 64:515-521. http://dx.doi.org/10 .1111/j.1558-5646.2009.00821.x.
29. Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. 2011. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob. Agents Chemother. 55:2655- 2661. http://dx.doi.org/10.1128/AAC.00045-11.
30. Papaioannou E, Wahjudi M, Nadal-Jimenez P, Koch G, Setroikromo R, Quax WJ. 2009. Quorum-quenching acylase reduces the virulence of Pseudomonas aeruginosa in a Caenorhabditis elegans infection model. Antimicrob. Agents Chemother. 53:4891-4897. http://dx.doi.org/10.1128 /AAC.00380-09.
31. Lutter EI, Duong J, Purighalla S, Storey DG. 2012. Lethality and cooperation of Pseudomonas aeruginosa quorum sensing mutants in Drosophila melanogaster infection models. Microbiology 158:2125-2132. http://dx.doi.org/10.1099/mic.0.054999-0.
32. Rumbaugh KP, Diggle SP, Watters CM, Ross-Gillespie A, Griffin AS, West SA. 2009. Quorum sensing and the social evolution of bacterial virulence. Curr. Biol. 19:341-345. http://dx.doi.org/10.1016/j.cub.2009 .01.050.
33. Rumbaugh KP, Griswold JA, Hamood AN. 1999. Contribution of the regulatory gene lasR to the pathogenesis of Pseudomonas aeruginosa infection of burned mice. J. Burn Care Rehabil. 20:42-49. http://dx.doi.org /10.1097/00004630-199901001-00008.
34. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN. 1999. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect. Immun. 67:5854-5862.
35. Rumbaugh KP, Trivedi U, Watters C, Burton-Chellew MN, Diggle SP, West SA. 2012. Kin selection, quorum sensing and virulence in pathogenic bacteria. Proc. Biol. Sci. 279:3584-3588. http://dx.doi.org/10.1098 /rspb.2012.0843.
36. Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, Prince A. 1996. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect. Immun. 64:37-43.
37. Kukavica-Ibrulj I, Levesque RC. 2008. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies. Lab. Anim. 42:389-412. http://dx.doi.org/10.1258/la.2007 .06014e.
38. Stoltz DA, Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, Davis GJ, Hanfland RA, Wohlford-Lenane C, Dohrn CL, Bartlett JA, Nelson GA, Chang EH, Taft PJ, Ludwig PS, Estin M, Hornick EE, Launspach JL, Samuel M, Rokhlina T, Karp PH, Ostedgaard LS, Uc A, Starner TD, Horswill AR, Brogden KA, Prather RS, Richter SS, Shilyansky J, McCray PB, Zabner J, Welsh MJ. 2010. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 28:29ra31. http://dx.doi.org/10.1126/scitranslmed .3000928.
39. Saiman L, Cacalano G, Prince A. 1990. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect. Immun. 58:2578-2584.
40. Zhu H, Thuruthyil SJ, Willcox MD. 2000. Invasive strains of Pseudomonas aeruginosa are able to cause epithelial cell cytotoxicity that is dependent on bacterial cell density. Clin. Exp. Ophthalmol. 28:201-204. http: //dx.doi.org/10.1046/j.1442-9071.2000.00289.x.
41. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, Thorneloe KS, McAlexander MA, Ingber DE. 2012. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4:159ra147. http://dx.doi.org/10.1126 /scitranslmed.3004249.
42. Nunes SF, Murcia PR, Tiley LS, Brown IH, Tucker AW, Maskell DJ, Wood JLN. 2010. An ex vivo swine tracheal organ culture for the study of influenza infection. Influenza Other Respir. Viruses 4:7-15. http://dx.doi .org/10.1111/j.1750-2659.2009.00119.x.
43. Hoffmann N, Rasmussen TB, Jensen PØ, Stub C, Hentzer M, Molin S, Ciofu O, Givskov M, Johansen HK, Høiby N. 2005. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73:2504-2514. http://dx.doi.org/10.1128/IAI .73.4.2504-2514.2005.
44. Pedersen SS, Shand GH, Hansen BL, Hansen GN. 1990. Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres. APMIS 98:203-211. http: //dx.doi.org/10.1111/j.1699-0463.1990.tb01023.x.
45. Kemp MW, Massey RC. 2007. The use of insect models to study human pathogens. Drug Discov. Today Dis. Models 4:105-110. http://dx.doi .org/10.1016/j.ddmod.2007.06.007.
46. Wiles S, Hanage WP, Frankel G, Robertson B. 2006. Modelling infectious disease-time to think outside the box? Nat. Rev. Microbiol. 4:307- 312. http://dx.doi.org/10.1038/nrmicro1386.
47. Hoffmann N. 2007. Animal models of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Drug Discov. Today Dis. Models 4:99- 104. http://dx.doi.org/10.1016/j.ddmod.2007.11.008.
48. Huang S, Wiszniewski L, Constant S. 2011. The use of in vitro 3D cell models in drug development for respiratory diseases, p 169 -190. In Kapetanovic IM (ed), Drug discovery and development-present and future. InTech, Rijeka, Croatia. http://dx.doi.org/10.5772/28132.
49. Schuster M, Sexton DJ, Diggle SP, Greenberg EP. 2013. Acylhomoserine lactone quorum sensing: from evolution to application. Annu. Rev. Microbiol. 67:43-63. http://dx.doi.org/10.1146/annurev -micro-092412-155635.
50. Köhler T, Buckling A, van Delden C. 2009. Cooperation and virulence of clinical Pseudomonas aeruginosa populations. Proc. Natl. Acad. Sci. U. S. A. 106:6339-6344. http://dx.doi.org/10.1073/pnas.0811741106.
51. Ghoul M, Griffin AS, West SA. 2014. Toward an evolutionary definition of cheating. Evolution 68:318-331. http://dx.doi.org/10.1111/evo.12266.
52. West SA, Griffin AS, Gardner A, Diggle SP. 2006. Social evolution theory for microorganisms. Nat. Rev. Microbiol. 4:597-607. http://dx .doi.org/10.1038/nrmicro1461.
53. Bjarnsholt T, Givskov M. 2007. Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens. Phil. Trans. R. Soc. B Biol. Sci. 362:1213-1222. http://dx.doi.org/10.1098/rstb.2007 .2046.
54. Defoirdt T, Brackman G, Coenye T. 2013. Quorum sensing inhibitors: how strong is the evidence? Trends Microbiol. 21:619-624. http://dx.doi .org/10.1016/j.tim.2013.09.006.
55. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C. 2007. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol. 7:45. http://dx.doi.org /10.1186/1471-2180-7-45.
56. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, Newman DK. 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell. Mol. Biol. 47:738-745. http://dx.doi.org/10.1165 /rcmb.2012-0088OC.
57. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ. 1988. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56:2515-2517.
58. Meyer JM, Neely A, Stintzi A, Georges C, Holder IA. 1996. Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect. Immun. 64: 518-523.
59. Buckling A, Harrison F, Vos M, Brockhurst MA, Gardner A, West SA, Griffin A. 2007. Siderophore-mediated cooperation and virulence in Pseudomonas aeruginosa. FEMS Microbiol. Ecol. 62:135-141. http://dx .doi.org/10.1111/j.1574-6941.2007.00388.x.
60. Harrison EF. 2007. Cooperative behaviour in Pseudomonas aeruginosa: ecology, evolution and pathology. D.Phil. thesis. University of Oxford, Oxford, United Kingdom.
61. Haas B, Kraut J, Marks J, Zanker SC, Castignetti D. 1991. Siderophore presence in sputa of cystic fibrosis patients. Infect. Immun. 59:3997- 4000.
62. Martin L, Reid D, Sharples K, Lamont I. 2011. Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24:1059- 1067. http://dx.doi.org/10.1007/s10534-011-9464-z.
63. Winson MK, Swift S, Fish L, Throup JP, Jørgensen F, Chhabra SR, Bycroft BW, Williams P, Stewart GSAB. 1998. Construction and analysis of luxCDABE-based plasmid sensors for investigating N-acyl homoserine lactone-mediated quorum sensing. FEMS Microbiol. Lett. 163: 185-192. http://dx.doi.org/10.1111/j.1574-6968.1998.tb13044.x.
64. Jiricny N, Diggle SP, West SA, Evans BA, Ballantyne G, Ross-Gillespie A, Griffin AS. 2010. Fitness correlates with the extent of cheating in a social bacterium. J. Evol. Biol. 23:738-747. http://dx.doi.org/10.1111/j .1420-9101.2010.01939.x.
65. Dumas Z, Ross-Gillespie A, Kümmerli R. 2013. Switching between apparently redundant iron-uptake mechanisms benefits bacteria in changeable environments. Proc. Biol. Sci. 280:20131055. http://dx.doi .org/10.1098/rspb.2013.1055.
66. Fox J, Weisberg S. 2011. An R companion to applied regression, 2nd ed. Sage, Thousand Oaks, CA.
67. Development Core Team R. 2011. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
68. Bakkal S, Robinson SM, Ordonez CL, Waltz DA, Riley MA. 2010. Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients. Microbiology 156:2058-2067. http://dx.doi.org /10.1099/mic.0.036848-0.
69. Harrison F, Paul J, Massey RC, Buckling A. 2008. Inter-specific competition and siderophore-mediated cooperation in Pseudomonas aeruginosa. ISME J. 2:49-55. http://dx.doi.org/10.1038/ismej.2007.96.
70. Hoffman LR, Déziel E, D'Argenio DA, Lepine F, Emerson J, Mc Namara S, Gibson RL, Ramsey BW, Miller SI. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 103: 19890-19895. http://dx.doi.org/10.1073/pnas.0606756104.
71. Riedel K, Hentzer M, Geisenberger O, Huber B, Steidle A, Wu H, Høiby N, Givskov M, Molin S, Eberl L. 2001. N-Acylhomoserinelactone- mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology 147:3249-3262.
72. Traverse CC, Mayo-Smith LM, Poltak SR, Cooper VS. 2013. Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections. Proc. Natl. Acad. Sci. U. S. A. 110:E250-E259. http://dx.doi.org/10.1073/pnas.1207025110.
73. Weaver VB, Kolter R. 2004. Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J. Bacteriol. 186:2376-2384. http://dx.doi.org/10.1128/JB.186.8.2376-2384.2004.
74. Griffin AS, West SA, Buckling A. 2004. Cooperation and competition in pathogenic bacteria. Nature 430:1024-1027. http://dx.doi.org/10.1038 /nature02744.
75. Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Robertson CF, Phelan PD. 2001. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur. Respir. J. 17:281-286. http://dx.doi.org/10.1183/09031936.01.17202810.
76. Willner D, Haynes MR, Furlan M, Hanson N, Kirby B, Lim YW, Rainey PB, Schmieder R, Youle M, Conrad D, Rohwer F. 2012. Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung. Am. J. Respir. Cell Mol. Biol. 46:127-131. http://dx.doi.org/10 .1165/rcmb.2011-0253OC.
77. Narisawa N, Haruta S, Arai H, Ishii M, Igarashi Y. 2008. Coexistence of antibiotic-producing and antibiotic-sensitive bacteria in biofilms is mediated by resistant bacteria. Appl. Environ. Microbiol. 74:3887-3894. http://dx.doi.org/10.1128/AEM.02497-07.
78. Slater FR, Bailey MJ, Tett AJ, Turner SL. 2008. Progress towards understanding the fate of plasmids in bacterial communities. FEMS Microbiol. Ecol. 66:3-13. http://dx.doi.org/10.1111/j.1574-6941.2008 .00505.x.
79. Hermsen R, Deris JB, Hwa T. 2012. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proc. Natl. Acad. Sci. U. S. A. 109:10775-10780. http://dx.doi.org/10.1073/pnas .1117716109.
80. Perron GG, Lee AEG, Wang Y, Huang WE, Barraclough TG. 2012. Bacterial recombination promotes the evolution of multi-drugresistance in functionally diverse populations. Proc. Biol. Sci. 279:1477- 1484. http://dx.doi.org/10.1098/rspb.2011.1933.
81. Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer K, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas J, Randell S, Boucher R, Doring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325. http://dx.doi.org/10.1172/JCI13870.
82. Alvarez-Ortega C, Harwood CS. 2007. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Mol. Microbiol. 65:153-165. http://dx.doi.org/10 .1111/j.1365-2958.2007.05772.x.
83. Chambers CE, Visser MB, Schwab U, Sokol PA. 2005. Identification of N-acylhomoserine lactones in mucopurulent respiratory secretions from cystic fibrosis patients. FEMS Microbiol. Lett. 244:297-304. http://dx.doi .org/10.1016/j.femsle.2005.01.055.
84. Favre-Bonté S, Pache J-C, Robert J, Blanc D, Pechère J-C, van Delden C. 2002. Detection of Pseudomonas aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients. Microb. Pathog. 32:143-147. http://dx .doi.org/10.1006/mpat.2001.0487.
85. Hooi DS, Bycroft BW, Chhabra SR, Williams P, Pritchard DI. 2004. Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. Infect. Immun. 72:6463-6470. http: //dx.doi.org/10.1128/IAI.72.11.6463-6470.2004.
86. Middleton B, Rodgers HC, Cámara M, Knox AJ, Williams P, Hardman A. 2002. Direct detection of N-acylhomoserine lactones in cystic fibrosis sputum. FEMS Microbiol. Lett. 207:1-7. http://dx.doi.org/10 .1111/j.1574-6968.2002.tb11019.x.
87. Singh PK, Schaefer AL, Parsek MR, Moninger TO, Welsh MJ, Greenberg EP. 2000. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407:762-764. http://dx.doi .org/10.1038/35037627.
88. Wu H, Song Z, Hentzer M, Andersen JB, Heydorn A, Mathee K, Moser C, Eberl L, Molin S, Høiby N, Givskov M. 2000. Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa. Microbiology 146:2481-2493.
89. Winstanley C, Fothergill JL. 2009. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol. Lett. 290:1-9. http://dx.doi.org/10.1111/j.1574-6968.2008.01394.x.
90. Diggle SP, Winzer K, Chhabra SR, Worrall KE, Cámara M, Williams P. 2003. The Pseudomonas aeruginosa quinolone signal molecule overcomes the cell density-dependency of the quorum sensing hierarchy, regulates rhl-dependent genes at the onset of stationary phase and can be produced in the absence of LasR. Mol. Microbiol. 50:29-43. http://dx .doi.org/10.1046/j.1365-2958.2003.03672.x.
91. Dekimpe V, Déziel E. 2009. Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology 155:712-723. http://dx.doi.org/10 .1099/mic.0.022764-0.
92. Beatson S, Whitchurch C, Sargent J, Levesque R, Mattick J. 2002. Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa. J. Bacteriol. 184:3605-3613. http://dx .doi.org/10.1128/JB.184.13.3605-3613.2002.
93. Darch SE, West SA, Winzer K, Diggle SP. 2012. Density-dependent fitness benefits in quorum-sensing bacterial populations. Proc. Natl. Acad. Sci. U. S. A. 109:8259 8263. http://dx.doi.org/10.1073/pnas .1118131109.
94. Diggle SP. 2010. Microbial communication and virulence: lessons from evolutionary theory. Microbiology 156:3503-3512. http://dx.doi.org/10 .1099/mic.0.045179-0.
95. Pai A, Tanouchi Y, You L. 2012. Optimality and robustness in quorum sensing (QS)-mediated regulation of a costly public good enzyme. Proc. Natl. Acad. Sci. U. S. A. 109:19810-19815. http://dx.doi.org/10.1073 /pnas.1211072109.
96. West SA, Diggle SP, Buckling A, Gardner A, Griffin AS. 2007. The social lives of microbes. Annu. Rev. Ecol. Evol. Syst. 38:53-77. http://dx .doi.org/10.1146/annurev.ecolsys.38.091206.095740.
97. Sandoz KM, Mitzimberg SM, Schuster M. 2007. Social cheating in Pseudomonas aeruginosa quorum sensing. Proc. Natl. Acad. Sci. U. S. A. 104:15876-15881. http://dx.doi.org/10.1073/pnas.0705653104.
98. Wilder CN, Diggle SP, Schuster M. 2011. Cooperation and cheating in Pseudomonas aeruginosa: the roles of the las, rhl and pqs quorum-sensing systems. ISME J. 5:1332-1343. http://dx.doi.org/10.1038/ismej.2011.13.
99. Brown SP, West SA, Diggle SP, Griffin AS. 2009. Social evolution in micro-organisms and a Trojan horse approach to medical intervention strategies. Phil. Trans. R. Soc. B Biol. Sci. 364:3157-3168. http://dx.doi .org/10.1098/rstb.2009.0055.
100. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Déziel E, Smith EE, Nguyen H, Ernst RK, Larson Freeman TJ, Spencer DH, Brittnacher M, Hayden HS, Selgrade S, Klausen M, Goodlett DR, Burns JL, Ramsey BW, Miller SI. 2007. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 64:512-533. http://dx.doi.org/10.1111/j.1365-2958.2007.05678.x.
101. Duan K, Surette MG. 2007. Environmental regulation of Pseudomonas aeruginosa PAO1 las and rhl quorum-sensing systems. J. Bacteriol. 189: 4827-4836. http://dx.doi.org/10.1128/JB.00043-07.
102. Heurlier K, Denervaud V, Haas D. 2006. Impact of quorum sensing on fitness of Pseudomonas aeruginosa. Int. J. Med. Microbiol. 296:93-102. http://dx.doi.org/10.1016/j.ijmm.2006.01.043.
103. Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK. 2013. Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways. mBio. 4(4):e00557-13. http://dx.doi.org/10.1128/mBio.00557-13.
104. Reid DW, Lam QT, Schneider H, Walters EH. 2004. Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur. Respir. J. 24:286-291. http://dx.doi.org/10.1183/09031936.04.00104803.
105. Stites SW, Plautz MW, Bailey K, O'Brien-Ladner AR, Wesselius LJ. 1999. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis. Am. J. Respir. Crit. Care Med. 160:796-801. http://dx.doi.org/10.1164/ajrccm.160.3.9811018.
106. Stites SW, Walters B, O'Brien-Ladner AR, Bailey K, Wesselius LJ. 1998. Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. Chest 114:814-819. http://dx.doi .org/10.1378/chest.114.3.814.
107. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558. http://dx.doi.org/10.1002/ppul.21011.
108. Lynch SV, Bruce KD. 2013. The cystic fibrosis airway microbiome. Cold Spring Harb. Perspect. Med. 3:a009738. http://dx.doi.org/10.1101 /cshperspect.a009738.
109. Moore JE, Shaw A, Millar BC, Downey DG, Murphy PG, Elborn JS. 2005. Microbial ecology of the cystic fibrosis lung: does microflora type influence microbial loading? Br. J. Biomed. Sci. 62:175-178.
110. Rogers GB, Hart CA, Mason JR, Hughes M, Walshaw MJ, Bruce KD. 2003. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol. 41:3548 -3558. http://dx.doi.org/10 .1128/JCM.41.8.3548-3558.2003.
111. Beck JM, Young VB, Huffnagle GB. 2012. The microbiome of the lung. Transl. Res. 160:258 -266. http://dx.doi.org/10.1016/j.trsl.2012 .02.005.
112. Huang YJ, Kim E, Cox MJ, Brodie EL, Brown R, Wiener-Kronish JP, Lynch SV. 2010. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 14:9 59. http://dx.doi.org/10.1089/omi.2009.0100.
113. Matkovic Z, Miravitlles M. 2013. Chronic bronchial infection in COPD. Is there an infective phenotype? Respir. Med. 107:10-22. http://dx.doi .org/10.1016/j.rmed.2012.10.024.
114. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, McCray PB, McLennan G, Meyerholz DK, Namati E, Ostedgaard LS, Prather RS, Sabater JR, Stoltz DA, Zabner J, Welsh MJ. 2008. The porcine lung as a potential model for cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L240-L263. http://dx.doi.org/10.1152/ajplung .90203.2008.